Birdwatch Note
2024-06-10 05:08:16 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
まずアストラゼネカは法廷文書で認めるまでもなく 接種者への説明文書で２１年から血小板減少を伴う血栓症のリスクを説明していますし https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf 厚労省の添付文書にも２１年４月の承認時からそのリスクは明記してあります。 https://www.mhlw.go.jp/content/11123000/000782717.pdf 日本は２０万回ほど使用しゼネカワクチンは既に使用を２２年９月には終了していますし https://www.yomiuri.co.jp/medical/20221001-OYT1T50112/ 逆にEUでデータが存在する２４か国中９か国で７０歳以上で3割以上がファイザー等のxbb対応コロナワクチンを接種しています(下記5P) 。 https://www.ecdc.europa.eu/sites/default/files/documents/interim-vaccine-overage-eu-eea-2023-24.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1799978720884855047
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1800032210143285649
- noteId - 1800032210143285649
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1717996096536
- tweetId - 1799978720884855047
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- まずアストラゼネカは法廷文書で認めるまでもなく 接種者への説明文書で２１年から血小板減少を伴う血栓症のリスクを説明していますし https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf https://web.archive.org/web/20210815102507/https://med2.astrazeneca.co.jp/safety/download/VAX02.pdf 厚労省の添付文書にも２１年４月の承認時からそのリスクは明記してあります。 https://www.mhlw.go.jp/content/11123000/000782717.pdf 日本は２０万回ほど使用しゼネカワクチンは既に使用を２２年９月には終了していますし https://www.yomiuri.co.jp/medical/20221001-OYT1T50112/ 逆にEUでデータが存在する２４か国中９か国で７０歳以上で3割以上がファイザー等のxbb対応コロナワクチンを接種しています(下記5P) 。 https://www.ecdc.europa.eu/sites/default/files/documents/interim-vaccine-overage-eu-eea-2023-24.pdf
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-06-10 05:08:16 UTC (1717996096536) |
2024-06-10 13:45:02 UTC (1718027102105) |
CURRENTLY_RATED_HELPFUL | 2024-06-11 02:27:24 UTC (1718072844058) |
CURRENTLY_RATED_HELPFUL | 2024-06-10 13:45:02 UTC (1718027102105) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-06-10 13:13:52 -0500 | Rating Details | |
| 2024-06-10 06:04:24 -0500 | Rating Details | |
| 2024-06-10 04:47:06 -0500 | Rating Details | |
| 2024-06-10 04:15:34 -0500 | Rating Details | |
| 2024-06-10 03:28:28 -0500 | Rating Details | |
| 2024-06-10 02:53:57 -0500 | Rating Details | |
| 2024-06-10 02:40:41 -0500 | Rating Details | |
| 2024-06-10 02:29:09 -0500 | Rating Details | |
| 2024-06-10 02:23:13 -0500 | Rating Details | |
| 2024-06-10 02:13:11 -0500 | Rating Details | |
| 2024-06-10 02:04:31 -0500 | Rating Details | |
| 2024-06-10 01:50:41 -0500 | Rating Details | |
| 2024-06-10 01:42:27 -0500 | Rating Details | |
| 2024-06-10 01:40:33 -0500 | Rating Details | |
| 2024-06-10 01:40:05 -0500 | Rating Details | |
| 2024-06-10 01:34:22 -0500 | Rating Details | |
| 2024-06-10 01:32:27 -0500 | Rating Details | |
| 2024-06-10 01:31:38 -0500 | Rating Details | |
| 2024-06-10 01:28:00 -0500 | Rating Details | |
| 2024-06-10 01:08:41 -0500 | Rating Details | |
| 2024-06-10 00:57:58 -0500 | Rating Details | |
| 2024-06-10 00:51:41 -0500 | Rating Details | |
| 2024-06-10 00:42:18 -0500 | Rating Details | |
| 2024-06-10 00:19:15 -0500 | Rating Details | |
| 2024-06-10 17:20:13 -0500 | Rating Details | |
| 2024-06-10 16:42:43 -0500 | Rating Details | |
| 2024-06-10 06:01:06 -0500 | Rating Details | |
| 2024-06-10 05:11:41 -0500 | Rating Details | |
| 2024-06-10 04:44:15 -0500 | Rating Details | |
| 2024-06-10 04:42:31 -0500 | Rating Details | |
| 2024-06-10 04:34:49 -0500 | Rating Details | |
| 2024-06-10 03:52:04 -0500 | Rating Details | |
| 2024-06-10 03:39:49 -0500 | Rating Details | |
| 2024-06-10 03:00:15 -0500 | Rating Details | |
| 2024-06-10 02:35:55 -0500 | Rating Details | |
| 2024-06-10 01:58:44 -0500 | Rating Details | |
| 2024-06-10 01:55:15 -0500 | Rating Details | |
| 2024-06-10 01:44:14 -0500 | Rating Details | |
| 2024-06-10 01:43:38 -0500 | Rating Details | |
| 2024-06-10 01:41:43 -0500 | Rating Details | |
| 2024-06-10 01:40:56 -0500 | Rating Details | |
| 2024-06-10 01:40:29 -0500 | Rating Details | |
| 2024-06-10 01:33:25 -0500 | Rating Details | |
| 2024-06-10 01:30:57 -0500 | Rating Details | |
| 2024-06-10 01:28:13 -0500 | Rating Details | |
| 2024-06-10 01:22:16 -0500 | Rating Details | |
| 2024-06-10 00:52:38 -0500 | Rating Details | |
| 2024-06-10 00:51:25 -0500 | Rating Details | |
| 2024-06-10 00:48:44 -0500 | Rating Details | |
| 2024-06-11 00:52:23 -0500 | Rating Details | |
| 2024-06-11 01:48:59 -0500 | Rating Details | |
| 2024-06-10 20:59:27 -0500 | Rating Details | |
| 2024-06-10 13:50:34 -0500 | Rating Details | |
| 2024-06-10 08:12:18 -0500 | Rating Details | |
| 2024-06-10 05:41:12 -0500 | Rating Details | |
| 2024-06-10 04:58:12 -0500 | Rating Details | |
| 2024-06-10 04:44:02 -0500 | Rating Details | |
| 2024-06-10 04:23:13 -0500 | Rating Details | |
| 2024-06-10 04:20:42 -0500 | Rating Details | |
| 2024-06-10 04:08:41 -0500 | Rating Details | |
| 2024-06-10 03:44:04 -0500 | Rating Details | |
| 2024-06-10 03:22:55 -0500 | Rating Details | |
| 2024-06-10 02:29:14 -0500 | Rating Details | |
| 2024-06-10 02:06:47 -0500 | Rating Details | |
| 2024-06-10 02:06:17 -0500 | Rating Details | |
| 2024-06-10 01:51:53 -0500 | Rating Details | |
| 2024-06-10 01:30:11 -0500 | Rating Details | |
| 2024-06-10 01:02:12 -0500 | Rating Details | |
| 2024-06-10 00:51:49 -0500 | Rating Details | |
| 2024-06-10 00:32:30 -0500 | Rating Details | |
| 2024-06-21 23:51:23 -0500 | Rating Details |